martes, 4 de diciembre de 2018

Medical News | Medical Articles - Multiple Sclerosis - Dec 4, 2018 Edition

Medical News | Medical Articles

 
 December 4, 2018 
 Multiple Sclerosis 
 The latest multiple sclerosis news from News Medical 
 Multiple Sclerosis and SmokingMultiple Sclerosis and Smoking
 
Smoking has been established as a risk factor for the onset and progression of multiple sclerosis (MS).
 
   Optic Neuritis and Multiple SclerosisOptic Neuritis and Multiple Sclerosis
 
Optic neuritis (ON) is characterized by inflammation of the optic nerve with acute loss of vision in one eye. It is among the initial manifestations of multiple sclerosis (MS) and occurs secondary to demyelination. Most reported cases are associated with MS; however, it may occur in isolation.
 
   Heat Intolerance in Multiple SclerosisHeat Intolerance in Multiple Sclerosis
 
Multiple sclerosis (MS) is a debilitating disease characterized by demyelination of axons in the central nervous system (CNS).
 
 Multiple sclerosis and smoking
 
Multiple sclerosis and smokingSmokers have a higher risk of MS compared to those who have never smoked, according to a study conducted in a Norwegian city. It is now thought that tobacco smoking interacts with a separate risk factor, namely, the Epstein-Barr virus, to increase the risk to almost twice that of non-smokers.
 
 
 Remyelination Strategies for Multiple Sclerosis
 
Remyelination Strategies for Multiple SclerosisMultiple sclerosis (MS) is a demyelinating disorder of the central nervous system which is among the biggest causes of physical disability in young adulthood. It is characterized by demyelinating changes to nerves and inflammation around blood vessels.
 
 
 Study provides new clues to origin and development of multiple sclerosis
 
Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis, shows that they might have a significant role in the development of the disease.
 
 
 Study provides new way to treat multiple sclerosis
 
Nerve cells stripped of their insulation can no longer carry vital information, leading to the numbness, weakness and vision problems often associated with multiple sclerosis. A new study shows an overlooked source may be able to replace that lost insulation and provide a new way to treat diseases like MS.
 
 
 Conceptual framework proposed to examine role of exercise in multiple sclerosis
 
Researchers have proposed a conceptual framework for examining the relationship between exercise and adaptive neuroplasticity in the population with multiple sclerosis (MS).
 
 
 Gut microbiota could play greater role in pathogenesis of MS than previously thought
 
In multiple sclerosis, a defective response of the body’s own immune system leads to brain tissue damage. Gastrointestinal microbiota could play a far greater role in the pathogenesis of the disease than previously assumed, researchers at the University of Zurich have now found.
 
 
 FDA approves ultra-high-field 7T Terra MRI scanner for clinical use
 
The ultra-high-field 7T Terra magnetic resonance imaging scanner at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute of the Keck School of Medicine of USC has received FDA approval for clinical use, opening up new avenues of care for patients with Alzheimer's disease, multiple sclerosis and other diseases that affect the brain.
 
 
 Expanding the knowledge about hippocampus to better understand cognitive deficits in MS
 
A recent article by a team of international experts on multiple sclerosis (MS) underscores the importance of expanding the knowledge base about the hippocampus in order to better understand the genesis of cognitive deficits and develop new treatment strategies.
 
 
 B cell accumulation triggers nervous system damage in MS
 
B cells are important in helping the immune system fight pathogens. However, in the case of the neurological autoimmune disease Multiple Sclerosis (MS) they can damage nerve tissue.
 
 
 Study examines effects of walking exercise training on cognitive function in people with MS
 
John DeLuca, PhD, senior vice president for Research and Training at Kessler Foundation, has received a $95,000 sub-award from EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada.
 

No hay comentarios:

Publicar un comentario